Flerie completes merger with Biosergen

Bitget2026/10/23 17:00

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Flerie has completed its merger with Biosergen, taking over all assets and liabilities.
The merged company retains the Flerie name and its Stockholm headquarters.
Biosergen’s operations have moved to a new subsidiary of Flerie Invest, Flerie’s wholly owned subsidiary.
Flerie issued 2,667,234 ordinary shares as merger consideration, exchanging one new ordinary share for every 31 Biosergen shares.
Merger consideration is expected around October 28, 2026, for shareholders recorded on October 26, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biosergen AB published the original content used to generate this news brief via Cision (Ref. ID: 20261023:BIT:9267:0) on October 23, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Flerie completes merger with Biosergen

You may also like

Crypto prices